Actively Recruiting
Trial of JMKX003801 in Healthy Participants
Led by Jemincare · Updated on 2024-09-26
70
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003801 Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Dose in Chinese Healthy Adult Participants
CONDITIONS
Official Title
Trial of JMKX003801 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Understand and agree to study procedures and possible side effects
- Healthy adults aged 18 to 45 years
- Body mass index (BMI) between 19 and 28 kg/m2
- Weight at least 45 kg for females or 50 kg for males
You will not qualify if you...
- Serious clinical diseases involving circulatory, respiratory, digestive, nervous, endocrine, blood, genitourinary, or psychiatric systems
- Use of any medications or Chinese herbal medicines within 2 weeks before consenting
- Pregnant or breastfeeding women
- Any other condition deemed unsuitable by the investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
H
Hongzhang Ji
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here